Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

RVNCRVNC
Showing 3 of 26 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in REVANCE THERAPEUTICS INC

As of its Q4 2024 13F, Citadel Advisors held 91,118 shares of RVNC (Revance Therapeutics), worth $276,999.

Final Value

$0

Final Shares

0

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%—
0
2024-Q4
New
91,118
-
$276,9990.0%—
36
2024-Q3
Exited
0
-100.0%
$00.0%—
0

Other major holders of RVNC: Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used